SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-049971
Filing Date
2024-04-22
Accepted
2024-04-22 16:05:53
Documents
6
Period of Report
2024-06-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm242755-1_def14a.htm DEF 14A 957798
2 GRAPHIC bc_companytsr-4c.jpg GRAPHIC 73497
3 GRAPHIC bc_netincome-4c.jpg GRAPHIC 66028
4 GRAPHIC lg_caratmtherap-4c.jpg GRAPHIC 20477
5 GRAPHIC px_24caratheraproxy1pg01-bw.jpg GRAPHIC 317097
6 GRAPHIC px_24caratheraproxy1pg02-bw.jpg GRAPHIC 233552
  Complete submission text file 0001104659-24-049971.txt   1899246
Mailing Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901
Business Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36279 | Film No.: 24861218
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)